Investor's Business Daily6h agoIovance, a top 1% biotech stock, crashes on surprise lung cancer twistIovance shares fell sharply Thursday, slipping below the 50-day line. Fresh doubts emerged in the market over the durability of its experimental lung cancer therapy. SourceDisclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.Stocks